VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
MNMD
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
MNMDMind Medicine (MindMed) Inc.
$20.69$2.0B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksMNMDQuarterly Financials

Mind Medicine (MindMed) Inc. (MNMD) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Mind Medicine (MindMed) Inc. (MNMD) quarterly income statement — complete revenue, gross profit & net income history

MNMD Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold00000000527K00000000000
COGS % of Revenue--------------------
Gross Profit00000000-527K00000000000
Gross Margin %--------------------
Gross Profit Growth %----100%---------------
Operating Expenses59.22M47.58M45.67M40.9M32.16M32.46M24.79M24.46M21.68M22.2M21.62M29.18M20.86M13.9M16.98M16.94M18.5M17.56M17.23M45.22M
OpEx % of Revenue--------------------
Selling, General & Admin17.74M14.06M14.69M11.09M8.8M10.7M7.6M9.81M10.5M10.66M8.41M14.41M8.26M5.07M9.21M7.62M8.26M6.67M8.21M37.15M
SG&A % of Revenue--------------------
Research & Development41.48M33.52M30.98M29.81M23.36M21.76M17.19M14.64M11.18M11.55M13.2M14.78M12.6M8.83M7.77M9.33M10.24M10.88M9.02M8.07M
R&D % of Revenue--------------------
Other Operating Expenses00000000000000000000
Operating Income-59.22M-47.58M-45.67M-40.9M-32.16M-32.46M-24.79M-24.46M-22.2M-22.2M-21.62M-29.18M-20.86M-13.9M-16.98M-16.94M-18.5M-17.56M-17.23M-45.22M
Operating Margin %--------------------
Operating Income Growth %-84.15%-46.57%-84.21%-67.24%-44.83%-46.19%-14.69%16.19%-6.43%-59.75%-27.28%-72.25%-12.74%20.83%1.42%62.53%-33.63%46.84%-130.18%-668.13%
EBITDA-59.22M-45.82M-45.66M-40.41M-22.75M-34.09M-12.96M-5.39M-21.68M-21.41M-20.82M-28.39M-20.07M-13.11M-16.19M-16.12M-17.73M-17.55M-16.44M-44.44M
EBITDA Margin %--------------------
EBITDA Growth %-160.35%-34.44%-252.41%-649.93%-4.93%-59.16%37.78%81.02%-8%-63.35%-28.61%-76.11%-13.24%25.32%1.49%63.72%-39.91%46.63%-123.77%-672.89%
D&A (Non-Cash Add-back)006.75K00011.84M0527K790K791K790K791K790K790K820K780K4K789K779K
EBIT-59.22M-45.82M-65.99M-40.41M-22.75M-34.09M-12.96M-5.39M-53.97M-22.2M-17.59M-29.05M-24.74M-13.9M-16.98M-16.94M-18.5M-17.56M-17.23M-45.22M
Net Interest Income2.21M-1.12M988K436K1.83M2.62M2.78M2.65M1.22M905K1.16M1.31M1.28M1.05M360K82K-27K-386K-64K-69K
Interest Income3.46M3.49M2.26M2.77M2.43M3.28M3.51M3.12M1.66M905K1.16M1.39M1.36M1.05M360K82K0-27K00
Interest Expense1.25M4.61M1.27M2.34M602K656K727K466K434K0077K76K00-27K359K64K69K
Other Income/Expense-17.88M-2.86M-21.6M-1.84M8.81M-2.28M11.11M18.6M-32.2M-1.66M3.69M54K-3.95M9M498K-14K54K-428K31K-32K
Pretax Income-77.1M-50.44M-67.27M-42.74M-23.35M-34.74M-13.68M-5.85M-54.4M-23.86M-17.92M-29.13M-24.82M-4.9M-16.48M-16.96M-18.45M-17.99M-17.2M-45.25M
Pretax Margin %--------------------
Income Tax00000000000000000-1.16M00
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%6.43%0%0%
Net Income-77.1M-50.44M-67.27M-42.74M-23.35M-34.74M-13.68M-5.85M-54.4M-23.86M-17.92M-29.13M-24.82M-4.9M-16.48M-16.96M-18.45M-16.83M-17.2M-45.25M
Net Margin %--------------------
Net Income Growth %-230.21%-45.18%-391.56%-630.17%57.08%-45.58%23.65%79.9%-119.22%-386.72%-8.72%-71.79%-34.49%70.87%4.13%62.53%-34.1%-34.5%-98.22%-691.53%
Net Income (Continuing)-77.1M-50.44M-67.27M-42.74M-23.35M-34.74M-13.68M-5.85M-54.4M-23.86M-17.92M-29.13M-24.82M-4.9M-16.48M-16.96M-18.45M-16.83M-17.2M-45.25M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.71-0.50-0.78-0.50-0.27-0.41-0.17-0.08-1.14-0.59-0.45-0.76-0.650.11-0.55-0.60-0.66-3.32-0.83-1.33
EPS Growth %-162.96%-21.95%-358.82%-514.25%76.32%30.51%62.22%89.29%-75.38%-636.36%18.18%-26.67%1.52%103.31%33.73%54.89%-15.79%-591.67%-80.43%-303.03%
EPS (Basic)-0.71-0.51-0.78-0.50-0.27-0.41-0.18-0.08-1.14-0.59-0.45-0.76-0.650.11-0.55-0.60-0.66-3.32-0.83-1.34
Diluted Shares Outstanding108.79M89.33M85.89M85.35M87.09M83.93M80.24M71.91M47.86M40.28M39.72M38.58M38.08M37.98M29.3M28.24M28.15M28.05M28.01M27.39M
Basic Shares Outstanding108.79M89.33M85.89M85.35M85.07M83.93M77.91M71.91M47.86M40.28M39.72M38.58M38.08M37.98M29.3M28.24M28.15M28.05M28M27.04M
Dividend Payout Ratio--------------------